12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gattex regulatory update

NPS completed submission of a rolling NDA to FDA for Gattex teduglutide to treat adults with short bowel syndrome (SBS). The company requested Priority Review...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >